Cargando…

A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics

Detalles Bibliográficos
Autores principales: Franciosi, Luigi, Diamant, Zuzana, Morelli, Nicoletta, de Kam, Marieke, Cohen, Adam, Walker, Michael, Page, Clive
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647361/
http://dx.doi.org/10.1186/2045-7022-3-S1-O13
_version_ 1782268722780569600
author Franciosi, Luigi
Diamant, Zuzana
Morelli, Nicoletta
de Kam, Marieke
Cohen, Adam
Walker, Michael
Page, Clive
author_facet Franciosi, Luigi
Diamant, Zuzana
Morelli, Nicoletta
de Kam, Marieke
Cohen, Adam
Walker, Michael
Page, Clive
author_sort Franciosi, Luigi
collection PubMed
description
format Online
Article
Text
id pubmed-3647361
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36473612013-05-10 A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics Franciosi, Luigi Diamant, Zuzana Morelli, Nicoletta de Kam, Marieke Cohen, Adam Walker, Michael Page, Clive Clin Transl Allergy Oral Presentation BioMed Central 2013-05-03 /pmc/articles/PMC3647361/ http://dx.doi.org/10.1186/2045-7022-3-S1-O13 Text en Copyright © 2013 Franciosi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Franciosi, Luigi
Diamant, Zuzana
Morelli, Nicoletta
de Kam, Marieke
Cohen, Adam
Walker, Michael
Page, Clive
A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
title A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
title_full A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
title_fullStr A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
title_full_unstemmed A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
title_short A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
title_sort combined phase i/iia study of the safety, bronchodilator and bronchoprotective effects of nebulized rpl554, a dual pde3/4-inhibitor, in healthy subjects and asthmatics
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647361/
http://dx.doi.org/10.1186/2045-7022-3-S1-O13
work_keys_str_mv AT franciosiluigi acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT diamantzuzana acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT morellinicoletta acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT dekammarieke acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT cohenadam acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT walkermichael acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT pageclive acombinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT franciosiluigi combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT diamantzuzana combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT morellinicoletta combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT dekammarieke combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT cohenadam combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT walkermichael combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics
AT pageclive combinedphaseiiiastudyofthesafetybronchodilatorandbronchoprotectiveeffectsofnebulizedrpl554adualpde34inhibitorinhealthysubjectsandasthmatics